# NGV · System, Appendage Closure, Left Atrial

_ ·  · Class 3_

**Canonical URL:** https://fda.innolitics.com/submissions/CV/CV-misc/NGV

## Overview

- **Product Code:** NGV
- **Device Name:** System, Appendage Closure, Left Atrial
- **Regulation:** 21 CFR N/A
- **Device Class:** 3
- **Review Panel:** [](/submissions/)
- **Implant:** yes

## Recent Cleared Devices (2 of 2)

| Record | Device Name | Applicant | Decision Date | Decision |
| --- | --- | --- | --- | --- |
| [P200049](https://fda.innolitics.com/submissions/CV/CV-misc/NGV/P200049.md) | Amplatzer™ Amulet™ Left Atrial Appendage Occluder | ABBOTT MEDICAL | Aug 14, 2021 | APPR |
| [P130013](https://fda.innolitics.com/submissions/CV/CV-misc/NGV/P130013.md) | WATCHMAN LEFT ATRIAL APPENDAGE (LAA) CLOSURE TECHNOLOGY | Boston Scientific Corp | Mar 13, 2015 | APPR |

## Top Applicants

- ABBOTT MEDICAL — 1 clearance
- Boston Scientific Corp — 1 clearance

---

**Source:** [https://fda.innolitics.com/submissions/CV/CV-misc/NGV](https://fda.innolitics.com/submissions/CV/CV-misc/NGV)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com